Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands |
Jun. 30, 2026 |
Mar. 31, 2026 |
|---|---|---|
| Payables and Accruals [Abstract] | ||
| Research and development expenses | $ 56,339 | $ 33,860 |
| Contractual costs related to batoclimab program discontinuation | 42,482 | 42,482 |
| Accrued bonuses | 5,256 | 16,767 |
| Legal and other professional fees | 677 | 1,342 |
| Other expenses | 2,210 | 2,430 |
| Accrued expenses and other current liabilities | $ 106,964 | $ 96,881 |
| X | ||||||||||
- Definition Accrued Contractual Costs Related To Batoclimab Program Discontinuation No definition available.
|
| X | ||||||||||
- Definition Accrued Liabilities And Other Liabilities, Current No definition available.
|
| X | ||||||||||
- Definition Accrued Research And Development Expenses No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|